InvestorsHub Logo
Followers 12
Posts 938
Boards Moderated 0
Alias Born 04/23/2009

Re: None

Wednesday, 07/15/2009 9:37:58 AM

Wednesday, July 15, 2009 9:37:58 AM

Post# of 192567
What's this all about????

CALGARY, Alberta, July 15, 2009 (GLOBE NEWSWIRE) -- Skymark Research, a leading provider of small- and micro-cap independent investment research, today initiated coverage on Enzyme Environmental Solutions, Inc. (Pink Sheets:EESO - News). Skymark Research is currently offering a complimentary trial subscription. To view our research go to: www.skymarkresearch.com

Related Quotes
Symbol Price Change
EESO.PK 0.00 0.00


{"s" : "eeso.pk","k" : "c10,l10,p20,t10","o" : "","j" : ""} About SMR:

Skymark Research is a leading provider of independent investment research in North America. Our services include research analysis on the small- and micro-cap markets, real-time news and financial data, market commentary and the SMR newsletter. Skymark Research's staff of small-cap investment professionals is dedicated to providing the small market's investment community with the tools and avenues necessary to make the important investment decisions. To view our research reports on a complimentary trial basis and take advantage of our other services, go to www.skymarkresearch.com and click on the complimentary trial subscription button on our home page, or go directly to our registration page at www.skymarkresearch.com/signup.php

About Enzyme Environmental Solutions, Inc.

Enzyme Environmental Solutions, Inc.(Pink Sheets:EESO - News) produces an enzyme solution used in a variety of special purpose products. The Company manufactures the enzyme products solution based on its formulas. The primary markets for the Company's products include retail, agricultural and industrial. The enzyme solution can be used to eliminate odor and organic matter, including blood stains to clean carpets and counter tops, remove wall paper, and as a cleaner/degreaser.

SMR Disclosure:

Skymarkresearch.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. Skymark Research has not been compensated by any of the above mentioned companies. Please read our report and visit our Web site, www.skymarkresearch.com, for complete risks and disclosures. CRD number 2203872.